Publication | Closed Access

EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor

InflammationMedicinal ChemistryAnti-inflammatoryMedicineImmunologyEgfr InhibitorsPharmacological AgentPharmacotherapyAnti-cancer AgentPharmacologyTumor MicroenvironmentDrug Discovery